Addus HomeCare (NASDAQ:ADUS) Cut to “Buy” at StockNews.com

StockNews.com cut shares of Addus HomeCare (NASDAQ:ADUSFree Report) from a strong-buy rating to a buy rating in a report published on Sunday.

Several other research analysts have also recently weighed in on the company. Oppenheimer boosted their price target on Addus HomeCare from $118.00 to $130.00 and gave the stock an outperform rating in a research note on Friday, June 7th. Stephens increased their price objective on shares of Addus HomeCare from $120.00 to $128.00 and gave the company an overweight rating in a research report on Friday, May 31st. Bank of America increased their price target on Addus HomeCare from $115.00 to $118.00 and gave the company a buy rating in a report on Tuesday, May 7th. Barclays lowered Addus HomeCare from an equal weight rating to an underweight rating and set a $83.00 price objective for the company. in a report on Tuesday, April 23rd. Finally, Macquarie started coverage on Addus HomeCare in a research report on Friday, June 28th. They issued an outperform rating and a $136.00 target price on the stock. One analyst has rated the stock with a sell rating and nine have given a buy rating to the company’s stock. Based on data from MarketBeat, the company presently has an average rating of Moderate Buy and a consensus target price of $116.25.

View Our Latest Research Report on Addus HomeCare

Addus HomeCare Trading Down 1.6 %

Addus HomeCare stock opened at $116.95 on Friday. Addus HomeCare has a 12 month low of $78.35 and a 12 month high of $120.53. The company has a current ratio of 1.35, a quick ratio of 1.35 and a debt-to-equity ratio of 0.14. The business’s fifty day simple moving average is $112.92 and its two-hundred day simple moving average is $101.06. The company has a market capitalization of $1.91 billion, a price-to-earnings ratio of 29.02, a price-to-earnings-growth ratio of 2.27 and a beta of 1.01.

Addus HomeCare (NASDAQ:ADUSGet Free Report) last announced its quarterly earnings data on Monday, May 6th. The company reported $1.21 EPS for the quarter, beating the consensus estimate of $0.97 by $0.24. The company had revenue of $280.70 million for the quarter, compared to the consensus estimate of $279.49 million. Addus HomeCare had a net margin of 6.04% and a return on equity of 10.03%. Addus HomeCare’s revenue for the quarter was up 11.6% on a year-over-year basis. During the same period in the prior year, the firm posted $0.84 EPS. As a group, equities analysts predict that Addus HomeCare will post 4.36 earnings per share for the current fiscal year.

Insiders Place Their Bets

In other Addus HomeCare news, EVP Roberton James Stevenson sold 217 shares of the company’s stock in a transaction that occurred on Monday, June 17th. The shares were sold at an average price of $116.13, for a total value of $25,200.21. Following the completion of the transaction, the executive vice president now directly owns 10,217 shares in the company, valued at $1,186,500.21. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. 4.60% of the stock is owned by company insiders.

Institutional Trading of Addus HomeCare

Several institutional investors have recently made changes to their positions in ADUS. Principal Securities Inc. bought a new position in Addus HomeCare in the 4th quarter worth approximately $26,000. GAMMA Investing LLC purchased a new position in shares of Addus HomeCare in the fourth quarter worth $34,000. EntryPoint Capital LLC bought a new position in shares of Addus HomeCare during the first quarter worth $44,000. Assetmark Inc. grew its stake in Addus HomeCare by 33.3% during the fourth quarter. Assetmark Inc. now owns 1,774 shares of the company’s stock valued at $165,000 after acquiring an additional 443 shares in the last quarter. Finally, Mesirow Financial Investment Management Inc. bought a new stake in Addus HomeCare in the 1st quarter valued at $234,000. Hedge funds and other institutional investors own 95.35% of the company’s stock.

Addus HomeCare Company Profile

(Get Free Report)

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.

Featured Stories

Analyst Recommendations for Addus HomeCare (NASDAQ:ADUS)

Receive News & Ratings for Addus HomeCare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Addus HomeCare and related companies with MarketBeat.com's FREE daily email newsletter.